Medicago Inc. COVID-19 vaccine candidate
0 sources
Medicago Inc. COVID-19 vaccine candidate
Summary
Medicago Inc. COVID-19 vaccine candidate is a vaccine type[1]. It draws 19 Wikipedia views per month (vaccine_type category, ranking #35 of 74).[2]
Key Facts
- Medicago Inc. COVID-19 vaccine candidate's instance of is recorded as vaccine type[3].
- Medicago Inc. COVID-19 vaccine candidate's developer is recorded as Laval University[4].
- Medicago Inc. COVID-19 vaccine candidate's developer is recorded as Medicago[5].
- Medicago Inc. COVID-19 vaccine candidate's subclass of is recorded as virus-like particle vaccine[6].
- Medicago Inc. COVID-19 vaccine candidate's subclass of is recorded as vaccine candidate[7].
- Medicago Inc. COVID-19 vaccine candidate's subclass of is recorded as vaccine[8].
- Medicago Inc. COVID-19 vaccine candidate's described by source is recorded as Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.[9].
- Medicago Inc. COVID-19 vaccine candidate's vaccine for is recorded as COVID-19[10].
- Medicago Inc. COVID-19 vaccine candidate's Google Knowledge Graph ID is recorded as /g/11n0llgw7m[11].
Why It Matters
Medicago Inc. COVID-19 vaccine candidate draws 19 Wikipedia views per month (vaccine_type category, ranking #35 of 74).[2] It has Wikipedia articles in 8 language editions, a strong signal of global cultural recognition.[12] It is known by 4 alternative names across languages and contexts.[13]